In aggressive MCL, the constitutive activation of the PI3K/AKT axis has also been associated to impaired PTEN [57], supporting the synergy between the blockage of BTK and the PI3K/mTOR/Akt pathways found in MCL cases. The gene discussed is MTOR; the disease is mantle cell lymphoma.